Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 6 of 6 citing Crowther: Oral vitamin K versus placebo to correct excessive anticoagulation in patients.... (0.07 sec) 

Last literature review version 17.2: Fri May 01 00: 00: 00 GMT 2009| This topic last …


HN Sokol, DM Rind - mt.aafp.org
Two large trials of prostate cancer screening have been published. In the
European Randomized Study of Screening for Prostate Cancer (ERSPC), prostate
cancer mortality was reduced by 20 percent with PSA screening, but the ...
Related articles - Cached - All 4 versions

[PDF] NICE-SUGAR


P Question, P Questions - N Engl J Med, 2009 - ichpnet.org
• Discuss the key findings of the papers presented • Critically evaluate the
papers by identifying strengths and weaknesses • Calculate the NNT or NNH if
applicable • Explain the clinical implications of each paper
Related articles - View as HTML

Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient


M Makris, JJ van Veen, R Maclean - Journal of thrombosis and thrombolysis - Springer
Abstract The management of patients with supra-thera- peutic INR in a common
clinical problem. The risk of bleeding is influenced by the intensity,
variability and duration of anticoagulation, patient age, presence of co- ...

Epidemiology and management of bleeding in patients using vitamin K antagonists


M Levi - Journal of Thrombosis and Haemostasis, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 1 - Related articles - All 3 versions

Article: Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients …


AI Med - Ann Intern Med, 2009 - Am Coll Physicians
In the March 3, 2009 issue, Crowther et al reported that 1.25 mg single dose of
vitamin-K has no value in reducing future bleeding in warfarin recipients with
INR 4.5-10.0 who were not bleeding (1). In this RCT, they enrolled 724 ...

Established anticoagulants in secondary haemostasis


Z für Laboratoriumsmedizin, CUB … - Hämostaseologie, 2009 - schattauer.de
Summary In respect to the actual discussion of new anti- coagulants in secondary
haemostasis, we will give a short review on established oral anti - coagulation
with vitamin K antagonists and parenteral anticoagulation by use of ...
Related articles - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google